Break Through Cancer Launches Two TeamLabs Targeting Acute Myelogenous Leukemia (AML)
Break Through Cancer Launches Two TeamLabs Targeting Acute Myelogenous Leukemia (AML) Novel research program embracing radical collaboration to discover potential AML treatments (CAMBRIDGE, MASS.) MAY 16, 2023 – Break Through Cancer, a collaborative medical research organization empowering researchers and physicians from top cancer research institutions to intercept and find cures for several of the world’s deadliest cancers, is announcing the launch of the Targeting Clonal Hematopoiesis to Prevent AML TeamLab and the Eradicating Minimal Residual Disease in AML TeamLab. AML begins in the blood-forming cells of the bone marrow and rapidly moves into the bloodstream, where it can quickly spread......